| Literature DB >> 31266161 |
Xuqin Song1, Tong Zhou1, Jiahui Zhang1, Yijuan Su2, Hao Zhou1, Limin He3.
Abstract
This study aimed to prepare a molecularly imprinted monolithic extraction column (MIMC) inside a micropipette tip by situ polymerization with roxithromycin as the dummy template. The polymers possessed excellent adsorption capacity and class-specificity to multiple macrolide drugs. MIMC was directly connected to a syringe for template removal and for the optimization of extraction conditions without any other post-treatment of polymers. A liquid chromatography-tandem mass spectrometric method was developed for the selective microextraction and determination of macrolide antibiotics in animal muscles based on MIMC. High recoveries of 76.1-92.8% for six macrolides were obtained with relative standard deviations less than 10.4%. MIMC exhibited better retention ability and durability when compared with the traditional C18 and HLB cartridges. The proposed method shows a great potential for the analysis of macrolide drugs at the trace level in animal foodstuffs.Entities:
Keywords: animal muscles; liquid chromatography-tandem mass spectrometry; macrolide antibiotics; microextraction; molecularly imprinted monolithic extraction column
Year: 2019 PMID: 31266161 PMCID: PMC6680429 DOI: 10.3390/polym11071109
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Schematic diagram of the preparation of molecularly imprinted monolithic column.
Figure 2Effect of molecularly imprinted monolithic column prepared by different functional monomers on the recovery of roxithromycin.
Figure 3Scanning electron microscope images of molecularly imprinted monolithic column (MIMC) and non-molecularly imprinted monolithic column (NIMC).
Specific adsorption capacities of MIMC and NIMC for single and multiple macrolides .
| Compound | Polymer | Single | Multiple | ||
|---|---|---|---|---|---|
| Q (mg/g) |
| Q (mg/g) |
| ||
| Roxithromycin | MIMC | 12.0 | 2.8 | 3.4 | 1.7 |
| NIMC | 4.3 | 1.9 | |||
| Clarithromycin | MIMC | 11.5 | 2.6 | 3.5 | 2.3 |
| NIMC | 4.5 | 1.5 | |||
| Erythromycin | MIMC | 11.5 | 2.3 | 8.2 | 2.1 |
| NIMC | 5.0 | 3.7 | |||
| Azithromycin | MIMC | 12.4 | 1.7 | 3.4 | 1.8 |
| NIMC | 7.2 | 1.9 | |||
| Tulathromycin | MIMC | 25.2 | 1.6 | 18.0 | 1.4 |
| NIMC | 18.4 | 12.9 | |||
| Tilmicosin | MIMC | 17.1 | 1.8 | 5.1 | 1.6 |
| NIMC | 9.3 | 3.2 | |||
| Spiramycin | MIMC | 10.2 | 2.0 | 4.8 | 1.8 |
| NIMC | 5.1 | 2.6 | |||
multiple macrolides (roxithromycin, clarithromycin, erythromycin, azithromycin, tulathromycin, tilmicosin and spiramycin), 200 mg/L of each drug in acetonitrile; MIMC, molecularly imprinted monolithic column; NIMC, non-molecularly imprinted monolithic column; Q, adsorption capacity; , imprinting factor.
Figure 4Effects of (A) methanol (MeOH), acetonitrile (ACN) and ethyl acetate (EA) as loading solvents and (B) MeOH, ACN, acetone and water as washing solvents on the recoveries of six macrolide drugs: erythromycin (ERY); clarithromycin (CLA); azithromycin (AZI); tulathromycin (TUL); tilmicosin (TIM); and, spiramycin (SPM).
Figure 5Class-specific adsorption capacities of MIMC and NIMC for six macrolides (same as Figure 4), florfenicol (FLO), sulfadimidine (SM2), and valnemulin (VAL).
Validation data for six macrolide antibiotics after molecularly imprinted polymer monolith microextraction (MIPMME) procedure in spiked animal muscle samples .
| Compound | Samples | Linearity (r2) | LOD | LOQ | Intra-Day Recovery (%RSD, | Inter-Day Recovery (%RSD, | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| 5 μg/kg | 10 μg/kg | 25 μg/kg | 5 μg/kg | 10 μg/kg | 25 μg/kg | |||||
| Erythromycin | chicken | 0.9977 | 0.5 | 2.0 | 80.4(4.2) | 82.8(2.7) | 85.4(1.7) | 81.2(5.1) | 83.3(2.4) | 86.1(2.5) |
| pork | 0.9984 | 0.5 | 2.0 | 81.7(3.8) | 83.4(3.1) | 84.8(5.9) | 82.7(4.4) | 83.9(3.6) | 85.6(6.7) | |
| beef | 0.9962 | 0.5 | 2.0 | 76.8(7.2) | 78.6(3.4) | 82.1(4.9) | 78.2(10.4) | 79.1(5.6) | 83.7(7.1) | |
| Clarithromycin | chicken | 0.9995 | 0.5 | 2.0 | 84.9(6.3) | 85.7(2.1) | 88.4(1.6) | 85.3(8.2) | 84.9(3.6) | 89.7(2.4) |
| pork | 0.9992 | 0.5 | 2.0 | 82.6(8.1) | 84.7(1.8) | 85.1(4.7) | 80.2(9.8) | 84.1(1.1) | 86.4(5.3) | |
| beef | 0.9989 | 0.5 | 2.0 | 80.5(4.7) | 82.6(0.7) | 84.6(4.2) | 82.9(5.1) | 83.7(2.6) | 85.1(3.9) | |
| Tulathromycin | chicken | 0.9992 | 1.0 | 5.0 | 75.8(5.8) | 78.1(3.4) | 79.1(2.3) | 76.1(3.7) | 78.6(1.9) | 80.3(2.7) |
| pork | 0.9994 | 1.0 | 5.0 | 76.8(1.2) | 78.8(6.1) | 80.2(1.9) | 77.5(1.6) | 79.2(3.4) | 81.2(2.1) | |
| beef | 0.9988 | 1.0 | 5.0 | 75.3(8.3) | 76.7(2.8) | 78.3(5.4) | 76.9(5.8) | 78.1(4.2) | 79.8(2.9) | |
| Azithromycin | chicken | 0.9963 | 0.5 | 2.0 | 83.5(2.5) | 84.8(2.2) | 85.7(3.6) | 83.9(1.4) | 84.4(3.6) | 87.4(7.2) |
| pork | 0.9998 | 0.5 | 2.0 | 85.1(7.3) | 88.4(5.4) | 91.7(6.7) | 86.3(8.1) | 89.1(4.5) | 92.8(3.1) | |
| beef | 0.9992 | 0.5 | 2.0 | 78.4(5.7) | 80.2(6.5) | 90.6(5.0) | 79.6(6.4) | 83.2(8.2) | 86.1(4.6) | |
| Spiramycin | chicken | 0.9961 | 1.0 | 5.0 | 84.6(3.2) | 86.9(1.2) | 87.6(1.1) | 85.3(5.8) | 87.2(2.7) | 87.6(4.1) |
| pork | 0.9987 | 1.0 | 5.0 | 82.3(4.1) | 83.4(8.3) | 85.8(1.7) | 83.5(2.5) | 84.8(7.2) | 85.7(3.6) | |
| beef | 0.9992 | 1.0 | 5.0 | 79.2(4.6) | 81.8(6.7) | 83.6(1.5) | 78.2(5.7) | 83.4(8.9) | 84.3(2.1) | |
| Tilmicosin | chicken | 0.9930 | 0.5 | 2.0 | 85.1(1.5) | 89.2(7.4) | 91.8(2.5) | 86.5(3.2) | 90.6(7.1) | 91.2(6.2) |
| pork | 0.9943 | 0.5 | 2.0 | 82.5(3.4) | 86.6(1.9) | 90.7(3.6) | 81.2(4.5) | 87.2(2.5) | 89.1(7.8) | |
| beef | 0.9985 | 0.5 | 2.0 | 79.4(1.9) | 84.2(6.4) | 88.1(2.7) | 78.2(2.2) | 86.2(8.1) | 90.3(4.5) | |
MIPMME, molecularly imprinted polymer monolith microextraction; LOD, limit of detection; LOQ, limit of quantification; RSD, relative standard deviation.
Figure 6Typical SRM chromatograms obtained from (A) spiked chicken matrix at the concentration of 5 μg/kg and (B) blank chicken matrix.
Comparison of the method developed with other reported methods.
| Preparation | Analytical Method | Matrix | Analyte | LOD (μg/kg) | Recovery (%) | Ref. |
|---|---|---|---|---|---|---|
| PLE | LC-MS/MS | chicken | SPM, TIM, TYL | 1.0–6.0 | 77.1–94.0 | [ |
| ASE | LC-MS/MS | pork, kidney, liver | SPM, OLE, ERE, DOR, IVE, TIM, ERY, ROX, CLA, KIT, MED | 0.2–0.6 | 76.0–102 | [ |
| MWNTs-MISPE | HPLC-UVD | chicken | ERY | - | 85.3–95.8 | [ |
| MMISPE | HPLC-UVD | pork, fish, shrimp | ERY, OLE, AZI, TIM, CLA, ROX | 1.5–20 | 64.8–84.2 | [ |
| HPMIP-DSPE | LC-MS/MS | honey | AZI, SPM, TIM, CLA, JOS, ROX, TYL | 0.003–0.017 | 88.0–117 | [ |
| MISPE | LC-MS/MS | pork, beef, chicken | AZI, TUL, SPM, TIM, ERY, CLA, ROX, MED, JOS, KIT | 0.1–0.4 | 60.7–100 | [ |
| MIPMME | LC-MS/MS | pork, beef, chicken | CLA, ERY, ZAI, TUL, TIM, SPM | 0.5–1.0 | 76.1–92.8 | This work |
PLE, pressurized liquid extraction; ASE, accelerated solvent extraction; MWNTs-MISPE, molecularly imprinted solid-phase extraction based on multi-walled carbon nanotubes; MMISPE, magnetic molecularly imprinted solid-phase extraction; MISPE, molecularly imprinted solid-phase extraction; HPMIP-DSPE, dispersive solid-phase extraction based on hollow porous molecularly imprinted polymers; MIPMME, molecularly imprinted polymer monolith microextraction; LC-MS/MS, liquid chromatography-tandem mass spectrometry; HPLC-UVD, high-performance liquid chromatography with ultraviolet detector; SPM, spiramycin; OLE, troleandomycin; ERE, erythromycin ethylsuccinate; DOR, doramectin; IVE, ivermectin; TIM, tilmicosin; ERY, erythromycin; ROX, roxithromycin; CLA, clarithromycin; KIT, kitasamycin; MED, midecamycin; JOS, josamycin; AZI, azithromycin; TYL, tylosin; LOD, limit of detection; LOQ, limit of quantitation.